TSA Medical Marijuana Policy: What Travelers Need to Know in 2026

Executive Summary

The Transportation Security Administration does not actively search for marijuana at airport security checkpoints, but federal law still classifies cannabis as a Schedule I controlled substance, creating legal complexity for medical marijuana patients traveling by air. While TSA screeners focus on detecting security threats rather than drugs, any cannabis discovered during screening must be reported to law enforcement. This policy leaves medical marijuana cardholders in a legal gray zone where state-authorized medicine remains federally prohibited, and the laws of both departure and arrival jurisdictions apply. The May 2026 clarification regarding Florida underscores that TSA policy does not override state criminal statutes, meaning patients face potential prosecution even when TSA allows products through screening. Understanding the intersection of federal aviation security, state medical marijuana programs, and interstate commerce law is essential for the estimated 3.6 million registered medical cannabis patients in the United States who may consider air travel with their medication.

Why This Matters

More than 3.6 million Americans hold valid medical marijuana cards across 38 states and four territories, and millions of these patients fly domestically each year with legitimate questions about traveling with state-authorized medicine. The TSA screens approximately 2.4 million passengers daily at U.S. airports, and the agency's stated policy on marijuana directly affects patient access to medication during travel for medical appointments, family emergencies, and relocations. The stakes extend beyond individual patients. The medical cannabis industry generated $13.2 billion in sales during 2025, with patient registries growing 18% year-over-year. Dispensaries, physicians, and patient advocacy organizations field thousands of inquiries monthly about air travel, yet provide guidance constrained by conflicting federal and state frameworks. Airlines, airport authorities, and local law enforcement agencies navigate inconsistent enforcement priorities, with some jurisdictions declining to prosecute small amounts while others maintain zero-tolerance approaches. The economic implications reach the tourism and hospitality sectors. States like Colorado, California, and Nevada market cannabis-friendly policies to attract visitors, but air travel restrictions limit interstate patient mobility. Medical tourism related to cannabis access represents an estimated $340 million annually, with patients traveling to access specific strains, concentrations, or product forms unavailable in their home states. TSA policy directly shapes whether patients can maintain medication continuity during such travel. For investors and operators, the TSA medical marijuana question reflects broader federal-state conflicts that constrain the cannabis industry. Multi-state operators cannot transport products across state lines, forcing duplicative cultivation and processing infrastructure. The inability to freely transport cannabis by air—even for medical purposes—exemplifies the regulatory fragmentation that adds costs and complexity throughout the supply chain.

Background and History

Pre-2001: Minimal Federal Aviation Security Oversight

Before the September 11, 2001 terrorist attacks, airport security screening was conducted by private contractors hired by airlines, with minimal federal standardization and no centralized marijuana policy. The Federal Aviation Administration maintained regulatory authority over aviation safety, but security screening focused primarily on weapons and explosives. Drug enforcement at airports fell to local and state police agencies, with widely varying approaches. Some jurisdictions treated small amounts of marijuana as low-priority offenses, while others aggressively prosecuted possession cases. The Controlled Substances Act of 1970 classified marijuana as Schedule I under 21 U.S.C. § 812, defining it as having no accepted medical use and high abuse potential. This federal prohibition applied in all U.S. territories and federal enclaves, including airports, regardless of state law. California's Proposition 215 in 1996 created the first modern state medical marijuana program, but offered no protection for patients in federal jurisdictions like airport terminals.

2001-2003: TSA Creation and Initial Policies

The Aviation and Transportation Security Act, signed November 19, 2001, created the Transportation Security Administration within the Department of Transportation, federalizing airport security screening nationwide. TSA assumed responsibility for screening all passengers and baggage at commercial airports by November 2002. The agency's primary mission focused on preventing weapons, explosives, and other security threats from entering aircraft. TSA's initial policies did not specifically address marijuana. Screeners operated under general instructions to report suspected criminal activity to law enforcement. Between 2002 and 2005, TSA referred approximately 8,400 cases annually to law enforcement for suspected drug violations, according to agency reports. These referrals occurred incidentally during searches for prohibited security items, not through targeted drug screening.

2006-2013: State Medical Programs Expand

By 2012, 18 states and the District of Columbia had enacted medical marijuana laws, creating growing tension between state patient protections and federal airport jurisdiction. Patient advocacy groups including Americans for Safe Access and the Marijuana Policy Project documented hundreds of cases where medical marijuana cardholders faced arrest, prosecution, or product confiscation at airports despite possessing valid state authorizations. Notable incidents included a 2011 case at Sacramento International Airport where a California medical marijuana patient had 2.3 ounces confiscated and faced county charges, despite possessing amounts within state limits. In Colorado, where medical marijuana became available in 2001, Denver International Airport implemented a policy allowing passengers to abandon cannabis in "amnesty boxes" before security screening, avoiding criminal referral. TSA maintained that screeners were not actively searching for drugs but would report violations discovered during security screening. The agency's 2009 guidance stated that TSA's focus remained on "threats to aviation and passengers," not law enforcement of drug statutes. However, the practical effect left medical marijuana patients vulnerable to arrest in federal airport terminals.

2014-2019: Evolving Enforcement Priorities

The December 2014 Rohrabacher-Farr Amendment prohibited the Department of Justice from using funds to prevent states from implementing medical marijuana laws, indirectly affecting airport enforcement in medical states. While this amendment (later renamed Rohrabacher-Blumenauer) did not bind TSA directly, it signaled shifting federal priorities. The Department of Justice under Attorney General Eric Holder issued the Cole Memorandum in 2013, deprioritizing federal marijuana enforcement in states with robust regulatory systems. TSA updated its website in May 2019 to clarify its marijuana policy. The agency stated that "TSA security officers do not search for marijuana or other illegal drugs," but that any substances discovered during screening would be referred to law enforcement. Critically, the policy noted that "TSA's screening procedures are focused on security and are designed to detect potential threats to aviation and passengers." This 2019 clarification represented the first explicit acknowledgment that marijuana was not a TSA screening priority. However, the policy maintained that discovered cannabis would trigger law enforcement referral, leaving the decision to local authorities. In practice, this meant outcomes varied dramatically by jurisdiction: Seattle-Tacoma International Airport and Portland International Airport adopted policies where local police would not respond to TSA referrals for marijuana possession within state legal limits, while airports in Texas, Georgia, and other prohibition states continued aggressive enforcement.

2020-2023: CBD and Hemp Confusion

The Agriculture Improvement Act of 2018 (2018 Farm Bill) legalized hemp containing no more than 0.3% delta-9 THC on a dry weight basis, creating new questions about CBD products at airport security. TSA updated its policy in January 2020 to explicitly allow "products that contain no more than 0.3 percent THC on a dry weight basis or that are approved by FDA." This change permitted passengers to travel with hemp-derived CBD products, provided they met the legal THC threshold. The CBD policy clarification did not extend to marijuana-derived products, even those with identical cannabinoid profiles. A CBD tincture derived from hemp remained legal for air travel, while an identical product derived from marijuana remained prohibited under federal law. This distinction proved confusing for passengers and screeners alike, as the products are visually and chemically indistinguishable without laboratory testing. Between 2020 and 2023, TSA processed record passenger volumes, screening 2.9 million passengers daily by summer 2023. The agency maintained its stated policy of not actively searching for marijuana while referring discovered cannabis to law enforcement. Data obtained through Freedom of Information Act requests showed TSA referred approximately 3,200 marijuana-related incidents to law enforcement in 2022, down from 8,400 annually in the early 2000s despite higher passenger volumes—a decline reflecting both policy changes and enforcement deprioritization in many jurisdictions.

2024-Present: State-Federal Tensions Intensify

As of May 2026, 38 states, four territories, and the District of Columbia have enacted medical marijuana programs, but marijuana remains Schedule I under federal law, creating an unresolved legal conflict at airports. The Drug Enforcement Administration initiated a rescheduling process in 2024 following a Department of Health and Human Services recommendation to move marijuana to Schedule III, but the process remains pending with no final rule published. The May 2026 news regarding Florida highlights the persistent gap between TSA screening policy and state criminal law. Florida legalized medical marijuana through a 2016 constitutional amendment and implemented its program in 2017, with over 800,000 registered patients as of 2026. However, Florida law prohibits marijuana possession without a valid Florida medical marijuana card, and does not recognize out-of-state cards. TSA's policy of allowing medical marijuana through screening does not override Florida's criminal statutes, meaning patients can face state prosecution even after clearing federal security. This creates a three-tier legal framework: TSA policy (not actively searching), federal law (Schedule I prohibition), and state law (varying from full prohibition to adult-use legalization). Patients must navigate all three layers, with potential criminal liability at each level depending on jurisdiction and circumstances.

Key Players

Transportation Security Administration

TSA, an agency within the Department of Homeland Security, employs approximately 50,000 Transportation Security Officers who screen passengers and baggage at 440 federally regulated airports. The agency's stated mission focuses on preventing security threats to aviation, not drug enforcement. TSA Administrator David Pekoske, who has led the agency since 2017, has maintained that screeners prioritize weapons and explosives over marijuana detection. TSA's official policy, published on its website and updated periodically, states that officers do not search for marijuana but will refer any discovered illegal substances to law enforcement. The agency has declined to issue specific guidance on medical marijuana, instead deferring to federal law's Schedule I classification while acknowledging that enforcement decisions rest with local authorities. TSA processed 2.4 million passengers daily in 2025, with marijuana-related law enforcement referrals representing less than 0.0001% of total screenings.

Drug Enforcement Administration

The DEA maintains marijuana's Schedule I classification under the Controlled Substances Act, defining it as having no currently accepted medical use in treatment in the United States. This classification applies in all federal jurisdictions, including airport terminals, regardless of state medical marijuana laws. DEA Administrator Anne Milgram has overseen the ongoing rescheduling review initiated in 2024, but no final rule has been published as of May 2026. The DEA does not maintain a significant presence at civilian airports for marijuana enforcement. The agency focuses resources on large-scale trafficking operations rather than individual patient possession. However, DEA's scheduling determination shapes the legal framework within which TSA, airlines, and local law enforcement operate.

State Medical Marijuana Programs

Thirty-eight states operate medical marijuana programs with widely varying structures, qualifying conditions, possession limits, and reciprocity provisions. States like California, Colorado, and Oregon have mature programs serving hundreds of thousands of patients, while newer programs in Mississippi and Alabama are still implementing regulations. Florida's Office of Medical Marijuana Use, within the Department of Health, oversees one of the nation's largest programs with over 800,000 registered patients as of 2026. Florida law allows qualified patients to possess up to a 70-day supply of medical marijuana as determined by their physician, but does not recognize out-of-state medical marijuana cards. This lack of reciprocity creates particular challenges at Florida airports, where TSA may allow products through screening but state law enforcement can arrest non-Florida cardholders for possession. Conversely, states including Arizona, Arkansas, Hawaii, Maine, Michigan, Nevada, New Hampshire, New Mexico, Oklahoma, Pennsylvania, Rhode Island, and Utah offer some form of reciprocity, recognizing out-of-state medical marijuana cards. These reciprocity provisions do not extend to air travel, as federal law governs airport terminals and aircraft.

Airlines and Airport Authorities

Commercial airlines operate under Federal Aviation Administration regulations and maintain policies prohibiting marijuana possession on aircraft, regardless of state medical marijuana laws. Airlines including American, Delta, United, and Southwest state in their contracts of carriage that passengers may not possess illegal drugs, including marijuana, which remains federally prohibited. Flight attendants and pilots can request law enforcement removal of passengers suspected of possessing cannabis. Airport authorities, typically operated by city or county governments, set policies for their facilities in coordination with local law enforcement. Denver International Airport, Los Angeles International Airport, and Seattle-Tacoma International Airport have implemented policies where local police will not cite passengers for marijuana possession within state legal limits, even when TSA refers cases. Conversely, airports in Dallas, Atlanta, and Charlotte maintain strict enforcement.

Patient Advocacy Organizations

Americans for Safe Access, the National Organization for the Reform of Marijuana Laws, and the Marijuana Policy Project have advocated for federal policy changes to protect medical marijuana patients during air travel. These organizations provide guidance to patients, document enforcement incidents, and lobby Congress for legislative solutions. Americans for Safe Access maintains a legal support network that has represented patients facing charges after airport marijuana discoveries. The advocacy groups argue that federal law should recognize state medical marijuana authorizations in the same manner as other prescription medications. They point to the Rohrabacher-Blumenauer Amendment as a model for broader protections, though that provision applies only to Department of Justice enforcement, not TSA screening or state prosecutions.

Legal and Regulatory Framework

Federal Controlled Substances Act

The Controlled Substances Act, codified at 21 U.S.C. § 801 et seq., classifies marijuana as a Schedule I controlled substance under 21 U.S.C. § 812(c), Schedule I(c)(10). Schedule I substances are defined as having a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. This classification makes marijuana possession, distribution, and manufacture federal crimes under 21 U.S.C. § 841, with penalties including imprisonment and fines. Federal law applies throughout the United States, including in states that have legalized medical or adult-use marijuana. The Supremacy Clause of the U.S. Constitution, Article VI, Clause 2, establishes that federal law supersedes conflicting state law. However, the federal government has limited resources and has historically deprioritized enforcement against individual patients in compliance with state medical marijuana programs. Possession of any amount of marijuana remains a federal misdemeanor under 21 U.S.C. § 844, punishable by up to one year imprisonment and a minimum fine of $1,000 for a first offense. Airport terminals, as federal enclaves or facilities subject to federal jurisdiction, fall under federal law enforcement authority, though in practice, local or state police typically respond to TSA referrals rather than federal agents.

Aviation and Transportation Security Act

The Aviation and Transportation Security Act, Public Law 107-71, enacted November 19, 2001, created TSA and mandated federal screening of all passengers and property before boarding aircraft. The Act, codified at 49 U.S.C. § 114, directs TSA to "provide for the screening of all passengers and property...before boarding" and to "prevent the carriage of any explosive, incendiary, or deadly or dangerous weapon" onto aircraft. The statute does not specifically mention drugs or marijuana. TSA's authority focuses on security threats to aviation, not general law enforcement. However, 49 U.S.C. § 114(h) requires TSA to "establish procedures for notifying the Administrator of the Federal Aviation Administration, appropriate State and local law enforcement officials, and airport or airline security officers of the identity of individuals known to pose, or suspected of posing, a risk of air piracy or terrorism or a threat to airline or passenger safety." This notification requirement forms the legal basis for TSA's policy of referring discovered marijuana to law enforcement, even though marijuana detection is not a primary screening objective. TSA interprets its statutory mandate as requiring referral of suspected criminal activity discovered during security screening, leaving prosecution decisions to law enforcement agencies.

State Medical Marijuana Statutes

State medical marijuana laws provide affirmative defenses or exemptions from state criminal penalties for qualified patients, but do not override federal law or create rights enforceable against federal agencies. For example, California's Compassionate Use Act of 1996, codified at California Health and Safety Code § 11362.5, exempts qualified patients and primary caregivers from state criminal penalties for possession and cultivation of marijuana for medical purposes. Florida's medical marijuana program, established by constitutional amendment in 2016 and implemented through Florida Statutes § 381.986, allows qualified patients to possess medical marijuana in amounts determined by their physician, typically up to a 70-day supply. Florida law specifies that possession without a valid Florida registry identification card remains a criminal offense, with no exception for out-of-state medical marijuana cards. The lack of interstate reciprocity creates particular challenges for air travelers. A patient with a valid California medical marijuana card traveling through Florida possesses state-legal medicine in California but commits a Florida criminal offense upon arrival. TSA's policy of allowing the product through screening in California does not provide legal protection in Florida.

Rohrabacher-Blumenauer Amendment

The Rohrabacher-Blumenauer Amendment, originally enacted as the Rohrabacher-Farr Amendment in December 2014, prohibits the Department of Justice from using appropriated funds to prevent states from implementing their own medical marijuana laws. The provision, included in annual appropriations bills and most recently in the Consolidated Appropriations Act, 2026, states that none of the funds made available to DOJ may be used to prevent states from implementing laws that authorize medical marijuana use, distribution, or cultivation. Federal courts have interpreted this amendment narrowly. In United States v. McIntosh, 833 F.3d 1163 (9th Cir. 2016), the Ninth Circuit held that the amendment prohibits DOJ from prosecuting individuals whose conduct is fully compliant with state medical marijuana law. However, the amendment does not decriminalize medical marijuana under federal law, does not bind agencies outside DOJ (such as TSA or DEA), and does not prevent state prosecutions. The amendment's practical effect on air travel is limited, as TSA operates under the Department of Homeland Security, not DOJ, and the amendment does not restrict state law enforcement from prosecuting marijuana possession at airports.

2018 Farm Bill and Hemp-Derived CBD

The Agriculture Improvement Act of 2018, Public Law 115-334, legalized hemp by removing it from the Controlled Substances Act's definition of marijuana. The Act, codified at 7 U.S.C. § 1639o, defines hemp as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition created a legal distinction between hemp-derived and marijuana-derived cannabinoids. CBD extracted from hemp containing no more than 0.3% THC is federally legal, while chemically identical CBD extracted from marijuana remains a Schedule I controlled substance. TSA's policy reflects this distinction, explicitly allowing hemp-derived CBD products while maintaining that marijuana-derived products are subject to federal prohibition. The practical challenge is that hemp-derived and marijuana-derived CBD products are indistinguishable without laboratory testing. TSA screeners cannot determine the source of a CBD product during security screening, creating inconsistent enforcement. In practice, TSA rarely refers CBD products to law enforcement, regardless of source, unless accompanied by other suspicious circumstances.

State-by-State Breakdown

California

California legalized medical marijuana in 1996 and adult-use marijuana in 2016, with possession of up to 28.5 grams legal for adults 21 and older without a medical card. California recognizes out-of-state medical marijuana cards for purposes of purchasing from dispensaries but not for legal possession protections, which extend only to California residents with state-issued cards. Los Angeles International Airport, Oakland International Airport, and other California airports have adopted policies where airport police will not cite passengers for marijuana possession within state legal limits, even when TSA refers cases. However, passengers flying to prohibition states remain subject to destination jurisdiction laws.

Colorado

Colorado's medical marijuana program began in 2001, followed by adult-use legalization in 2012, with possession of up to one ounce legal for adults 21 and older. Denver International Airport implemented a policy allowing passengers to dispose of marijuana in amnesty boxes before security screening, avoiding criminal referral. Denver police will not cite passengers for marijuana possession within state legal limits when TSA refers cases. However, airport signage warns that marijuana remains illegal under federal law and in many destination states. Colorado does not recognize out-of-state medical marijuana cards for possession purposes.

Florida

Florida legalized medical marijuana through a constitutional amendment in 2016, with the program implemented in 2017 serving over 800,000 registered patients as of 2026. Florida law allows qualified patients to possess up to a 70-day supply as determined by their physician, but does not recognize out-of-state medical marijuana cards. Florida Statutes § 381.986 specifies that possession without a valid Florida registry identification card remains a criminal offense, punishable as a first-degree misdemeanor for amounts under 20 grams. This creates significant risk for travelers at Florida airports, where TSA may allow medical marijuana through screening but state law enforcement can arrest non-Florida cardholders. Miami International Airport, Orlando International Airport, and Tampa International Airport enforce Florida law strictly, with local police responding to TSA referrals.

New York

New York legalized medical marijuana in 2014 and adult-use marijuana in 2021, with possession of up to three ounces legal for adults 21 and older. New York recognizes out-of-state medical marijuana cards, allowing visiting patients to purchase from New York dispensaries and possess marijuana within state limits. However, this reciprocity does not extend to air travel, as federal law governs airports. John F. Kennedy International Airport and LaGuardia Airport policies defer to Port Authority Police, who generally do not prosecute small amounts within state legal limits but maintain discretion to enforce federal law.

Texas

Texas operates a limited medical marijuana program restricted to low-THC cannabis (no more than 1% THC) for specific qualifying conditions, with no adult-use legalization. Texas law does not recognize out-of-state medical marijuana cards, and possession of any amount of marijuana remains a criminal offense under Texas Health and Safety Code § 481.121, except for patients enrolled in the Texas Compassionate Use Program. Dallas/Fort Worth International Airport, George Bush Intercontinental Airport, and other Texas airports maintain strict enforcement, with local police responding to all TSA marijuana referrals and filing criminal charges. Texas represents one of the highest-risk states for medical marijuana patients traveling by air.

Illinois

Illinois legalized medical marijuana in 2013 and adult-use marijuana in 2020, with possession of up to 30 grams legal for adults 21 and older. Illinois recognizes out-of-state medical marijuana cards, allowing visiting patients to possess marijuana within state limits. Chicago O'Hare International Airport and Chicago Midway International Airport have adopted policies where Chicago Police will not cite passengers for marijuana possession within state legal limits when TSA refers cases. However, airport signage warns that federal law prohibits marijuana and that destination state laws apply.

Washington

Washington legalized medical marijuana in 1998 and adult-use marijuana in 2012, with possession of up to one ounce legal for adults 21 and older. Washington does not recognize out-of-state medical marijuana cards for possession purposes, but adult-use legalization provides broader protections. Seattle-Tacoma International Airport implemented a policy in 2018 where Port of Seattle Police will not cite passengers for marijuana possession within state legal limits, even when TSA refers cases. The airport's official guidance states that passengers may possess marijuana in amounts legal under Washington law, but warns that federal law and destination state laws still apply.

Massachusetts

Massachusetts legalized medical marijuana in 2012 and adult-use marijuana in 2016, with possession of up to one ounce legal for adults 21 and older. Massachusetts recognizes out-of-state medical marijuana cards for purchasing purposes but not for possession protections, which extend to all adults 21 and older under adult-use law. Logan International Airport in Boston defers to Massachusetts State Police, who generally do not prosecute amounts within state legal limits but maintain discretion to enforce federal law. Massachusetts requires marijuana to be transported in sealed, child-resistant packaging.

Nevada

Nevada legalized medical marijuana in 2001 and adult-use marijuana in 2017, with possession of up to one ounce legal for adults 21 and older. Nevada recognizes out-of-state medical marijuana cards, allowing visiting patients to purchase from Nevada dispensaries and possess marijuana within state limits. McCarran International Airport in Las Vegas has implemented amnesty boxes where passengers can dispose of marijuana before screening, and Las Vegas Metropolitan Police generally do not respond to TSA referrals for amounts within state legal limits. However, airport signage warns that federal law prohibits marijuana on aircraft.

Ohio

Ohio legalized medical marijuana in 2016, with the program operational since 2019 serving approximately 250,000 registered patients as of 2026. Ohio does not recognize out-of-state medical marijuana cards, and possession without a valid Ohio registry identification card remains a criminal offense. Ohio legalized adult-use marijuana through a ballot initiative in 2023, with possession of up to 2.5 ounces legal for adults 21 and older as of December 2024. Cleveland Hopkins International Airport and John Glenn Columbus International Airport enforce Ohio law, with local police responding to TSA referrals and filing charges against non-Ohio cardholders possessing amounts exceeding adult-use limits.

Market and Business Implications

Multi-State Operator Constraints

The prohibition on transporting marijuana across state lines, even by air for medical purposes, forces multi-state operators to maintain duplicative cultivation, processing, and testing infrastructure in each state where they operate. Companies including Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs operate vertically integrated facilities in multiple states, unable to achieve economies of scale through centralized production. This regulatory fragmentation adds an estimated 30-40% to operational costs compared to a unified national market. The inability to transport cannabis by air also prevents MSOs from efficiently managing inventory across their networks. A surplus of a particular strain in Colorado cannot be redirected to meet demand in Florida, forcing operators to either discount excess inventory or allow it to age past optimal freshness. This inefficiency reduces margins and limits product consistency across state markets.

Patient Access and Medical Tourism

Air travel restrictions limit patient access to specialized medical marijuana products, strains, and concentrations unavailable in their home states. Patients seeking specific cannabinoid ratios, terpene profiles, or product forms often must travel to access them, but cannot transport products home by air. This creates a medical tourism market estimated at $340 million annually, with patients traveling to states like California, Colorado, and Oregon for consultations and product purchases, then either consuming products during extended stays or arranging ground transportation home. The restriction particularly affects patients with rare conditions or those who have found relief with specific cultivars. A patient in Texas who responds well to a high-CBD, low-THC strain available in Colorado cannot legally transport that product home by air, forcing them to either relocate, make repeated trips, or attempt to find similar products within Texas's limited medical program.

Ancillary Business Opportunities

The legal complexity surrounding air travel with medical marijuana has created opportunities for ancillary businesses including legal consultation, travel planning, and product sourcing services. Companies like CannaReps and Leafly offer services helping patients identify reciprocal states, locate dispensaries near airports, and understand local laws. Legal firms specializing in cannabis law provide retainer services for patients who travel frequently, offering representation if arrested. Some dispensaries near major airports have developed business models focused on travelers, offering small-quantity purchases and travel-friendly packaging. Dispensaries within 10 miles of Denver International Airport, Los Angeles International Airport, and McCarran International Airport report that 15-25% of customers identify as travelers, according to industry surveys. These dispensaries provide guidance on TSA policy and local laws, though they cannot guarantee legal protection.

Insurance and Liability Considerations

The ambiguous legal status of traveling with medical marijuana creates liability questions for dispensaries, physicians, and patient advocacy organizations that provide travel guidance. Dispensaries that advise patients on air travel with medical marijuana risk potential liability if patients face arrest or prosecution. Some dispensaries have adopted policies of providing only factual information about TSA policy and state laws, without recommendations, to limit liability exposure. Medical marijuana physicians face similar concerns. Doctors who certify patients for medical marijuana programs cannot legally recommend violating federal law by transporting marijuana across state lines or through airports. Medical boards in several states have issued guidance reminding physicians that their recommendations must comply with both state and federal law, creating a chilling effect on physician willingness to discuss travel with patients.

What Experts Say

Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws, has stated that TSA's policy creates a "legal trap" for medical marijuana patients. According to Armentano, the agency's position that screeners do not actively search for marijuana provides false reassurance to patients who may face prosecution under federal or state law if cannabis is discovered. NORML recommends that patients avoid air travel with marijuana and instead identify dispensaries at their destination in states with reciprocity or adult-use legalization. Deborah Jeffries, executive director of Americans for Safe Access, has emphasized that medical marijuana patients deserve the same protections as patients using other prescription medications. Jeffries has called for federal legislation explicitly protecting medical marijuana patients during interstate travel, similar to protections afforded to patients carrying other controlled substances with valid prescriptions. Americans for Safe Access has documented over 200 cases since 2015 where medical marijuana patients faced criminal charges after TSA discovered cannabis during airport screening. Former TSA Administrator John Pistole, who led the agency from 2010 to 2014, explained in a 2019 interview that TSA's mission focuses on aviation security, not drug enforcement. According to Pistole, TSA screeners receive training to identify weapons, explosives, and other security threats, not to detect drugs. However, Pistole acknowledged that screeners must refer suspected criminal activity to law enforcement when discovered during screening, creating the current policy framework. Hilary Bricken, an attorney specializing in cannabis law at Harris Bricken, has advised clients that TSA policy does not override federal or state criminal law. According to Bricken, patients who travel with medical marijuana assume legal risk at multiple levels: federal prosecution under the Controlled Substances Act, state prosecution in non-reciprocal states, and potential airline sanctions including flight denial and travel bans. Bricken recommends that patients consult legal counsel before traveling with medical marijuana and consider alternatives including identifying dispensaries at their destination. Dr. Peter Grinspoon, a physician and medical marijuana specialist at Massachusetts General Hospital, has noted that the inability to travel with medical marijuana creates continuity of care challenges for patients. According to Grinspoon, patients with chronic conditions who have achieved symptom control with specific cannabis products face difficult choices when traveling: discontinue medication, risk prosecution by traveling with cannabis, or avoid air travel entirely. Grinspoon has called for federal rescheduling of marijuana to resolve these conflicts.

Law Enforcement Perspectives

Airport police agencies have adopted widely varying approaches to TSA marijuana referrals, reflecting local enforcement priorities and political pressures. The Los Angeles Airport Police, which serves Los Angeles International Airport, implemented a policy in 2018 allowing passengers to travel with marijuana in amounts legal under California law. According to airport police statements, officers will not cite passengers for marijuana possession within state limits, even when TSA refers cases, unless other criminal activity is suspected. Conversely, Dallas/Fort Worth International Airport Department of Public Safety maintains a policy of prosecuting all marijuana possession cases referred by TSA, regardless of amount or medical status. According to department statements, marijuana remains illegal under federal and Texas law, and the department's jurisdiction as a federal airport requires enforcement of federal statutes. This strict enforcement approach reflects broader Texas policy opposing marijuana legalization.

What's Next

DEA Rescheduling Decision

The Drug Enforcement Administration's pending decision on rescheduling marijuana from Schedule I to Schedule III represents the most significant near-term development affecting TSA medical marijuana policy. The DEA